Clearly, this set of findings in many treated
euthyroid FMS patients shows that they meet Refetoff's definition of thyroid hormone resistance: «reduced responsiveness of target tissues to concentrations of thyroid hormone that under normal conditions would be excessive».
We find that approximately 75 % of
euthyroid FMS patients markedly improve or completely recover when treated with what we term «metabolic rehabilitation.»
Since that early open trial, my colleagues and I have continued to treat
euthyroid FMS patients on the assumption that they have thyroid hormone resistance.
Not exact matches
Based on communication with Usala and other thyroid hormone resistance researchers, in 1990, my colleagues and I treated 77
euthyroid female
FMS patients with the active thyroid hormone called T3 (as part of more comprehensive metabolic treatment).